Clinical trials: Stroke Prevention
Cerebral Infarction
Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke
This study evaluate the effects of acupuncture method on the recurrence of ischemic stroke patients.Half of participants will receive "Huo Xue San Feng" acupuncture combining 1 antihypertensive medication on the routine ischemic…
- Trial name
- NCT02967484
- Testing
- acupuncture
- Where
- 5 sites in China
- Volunteers
- 480 people
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Prevention & Control
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
The primary objectives of this study are: To determine whether rivaroxaban 2.5 mg twice daily (bid) + aspirin 100 mg once daily (od) compared with aspirin 100 mg od reduces the risk of a composite of myocardial infarction…
- Trial name
- COMPASS (NCT01776424)
- Testing
- Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Pantoprazole
- Where
- 565 sites in United States, Argentina and 31 more
- Volunteers
- 27,395 people
- Sponsor
- Bayer
Anemia, Sickle Cell, Blood Disease
Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
To conduct a prospective study aimed at the early detection and treatment of cerebral vascular disease prior to irreversible brain injury in young children with sickle cell anemia (SCA).
- Conditions
- Anemia, Sickle Cell, Blood Disease, Cerebrovascular Disorders, Cerebrovascular Accident
- Trial name
- NCT00005327
- Sponsor
- University of Southern California
Ischemic Stroke
The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke
It has been reported that stroke is the first cause of becoming bedridden, and its cumulative recurrence rate in 5 years is approximately 35%.
- Trial name
- NCT02121327
- Testing
- disease management, usual care
- Where
- Japan
- Volunteers
- 321 people
- Sponsor
- Hiroshima University
Stroke
Secondary Prevention By Structured Semi-Interactive Stroke Prevention Package in INDIA (SPRINT INDIA) Study
Recurrent stroke, cardiovascular morbidity and mortality are important causes of poor outcome in patients with index stroke. According to the INTERSTROKE study, 80% of stroke are preventable due to the presence of modifiable risk…
- Trial name
- SPRINT (NCT03228979)
- Testing
- Structured Semi-Interactive Stroke Prevention Package
- Where
- India
- Volunteers
- 5,830 people
- Sponsor
- Christian Medical College and Hospital, Ludhiana, India
Thromboembolic Stroke, Aspirin
The Prevention of Thromboembolic Complications Associated With Coil Embolization
Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.
- Conditions
- Thromboembolic Stroke, Aspirin, Clopidogrel, Coil Embolization
- Trial name
- NCT05512546
- Testing
- Aspir-Low Pill
- Where
- Pakistan
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Muhammad Hassan